The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain
The MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Case Series Study: Treatment of Head Pain With the SPRINT® Peripheral Nerve Stimulation (PNS) System
1 other identifier
interventional
50
1 country
10
Brief Summary
The purpose of this study is to learn if pain can be relieved by delivering small amounts of electricity (called "electrical stimulation") to the nerves at the top of the neck. This study will use a device called the SPRINT® PNS System. PNS stands for peripheral nerve stimulation (PNS). This device is cleared by the FDA for up to 60 days of use for relief of chronic or acute pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2022
CompletedFirst Posted
Study publicly available on registry
August 8, 2022
CompletedStudy Start
First participant enrolled
October 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
December 17, 2025
December 1, 2025
4.8 years
August 4, 2022
December 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (17)
Reduction in average pain and/or reduction in pain interference.
Average pain is measured using question 5 from the Brief Pain Inventory-Short Form (BPI-5) and pain interference is measured using question 9 from the Brief Pain Inventory-Short Form (BPI-9). BPI-5 is a scale of 0 to 10 where 0 represents no pain and 10 represents worst pain. BPI-9 is a scale of 0 to 10 where 0 represents no interference and 10 represents complete interference.
Up to 8-weeks after Start of Therapy (SOT)
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
During the Lead Placement procedure (SOT)
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
24-48 hours post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
1-week post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
2-weeks post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
3-weeks post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
4-weeks post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
5-weeks post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
6-weeks post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
7-weeks post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
8-weeks post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
3-months post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
6-months post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
9-months post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
12-months post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
18-months post-SOT
Study-Related Adverse Events (AEs)
Occurrence and type of study-related AEs
24-months post-SOT
Secondary Outcomes (3)
Reduction in average pain intensity
Baseline, 8-weeks after SOT, 3-months after SOT, 6-months after SOT, 9-months after SOT, 12-months after SOT
Reduction in pain interference
Baseline, 8-weeks after SOT, 3-months after SOT, 6-months after SOT, 9-months after SOT, 12-months after SOT
Reduction in pain medication usage
Baseline, 8-weeks after SOT, 3-months after SOT, 6-months after SOT, 9-months after SOT, 12-months after SOT
Study Arms (1)
Peripheral Nerve Stimulation
EXPERIMENTALAll study subjects will have up to 2 leads placed in the back of their neck, will use the SPRINT Peripheral Nerve Stimulation (PNS) System, and will receive electrical stimulation.
Interventions
The SPRINT System delivers mild electrical stimulation to the occipital nerves. The SPRINT System includes up to two leads (small wires) that are placed through your skin at the top of your neck. The leads attach to devices worn on your body that deliver stimulation (called Stimulators).
Eligibility Criteria
You may qualify if:
- Diagnosed cervicogenic headache (CGH) or occipital neuralgia (ON)
You may not qualify if:
- Prior cervical or cranial occipital surgery
- Implanted electronic device (dependent on implant's intended treatment, location, and electrical current pathway)
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
Pacific Research Institute
Santa Rosa, California, 95403, United States
MedVadis Research
Waltham, Massachusetts, 02451, United States
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Center of Clinical Research
Winston-Salem, North Carolina, 27103, United States
Pain Specialists of America - South Austin - James Casey
Austin, Texas, 78745, United States
Pain Specialists of America - Cedar Park
Cedar Park, Texas, 78613, United States
Institute of Precision Pain Medicine
Corpus Christi, Texas, 78414, United States
Pain Specialists of America - Round Rock
Round Rock, Texas, 78681, United States
Pain Specialists of America - San Marcos
San Marcos, Texas, 78666, United States
University of Utah
Salt Lake City, Utah, 84108, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2022
First Posted
August 8, 2022
Study Start
October 24, 2022
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
December 17, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share